Biological Products, (No Diagnostic Substances) · L3 · CIK 1119774
Compugen Ltd. discovers and develops cancer immunotherapies using its AI/ML platform
Comparable business profile · signals at a glance
In the 90 days to Mar 26, 2026: 1 sold $24K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Levine ZuritSVP, Business Development | Sell | 11,875 | $2.04 | $24K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.